News and Announcements
Universal Biosensors Investor Newsletter December 2015
- Published December 16, 2015 2:57PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
As we approach Christmas and the holiday season, we look back at what’s been an eventful year for Universal Biosensors. The year is also ending on a high for innovative companies like UBI with the release of the Federal Government’s innovation policy.
- FROM THE CEO’S DESK
- FEDERAL GOVERNMENT INNOVATION POLICY
- Q&A WITH GARRY CHAMBERS, VP OF TECHNOLOGY DEVELOPMENT
- POINT OF CARE MARKET EXPECTED TO GROW STRONGLY
- SPREADING THE UBI WORD
- J&J SYNCS BLOOD GLUCOSE DATA WITH APPLE HEALTH APP
FROM THE CEO’S DESK
Universal Biosensors has had a year of significant progress and development that’s put us in a strong position to grow further in 2016.
Read more.
FEDERAL GOVERNMENT INNOVATION POLICY
The federal government’s focus on innovation is a welcome development that recognises the importance of our high tech sector and the role it will play in Australia’s economic and social future.
Read more.
Q&A WITH GARRY CHAMBERS, VP OF TECHNOLOGY DEVELOPMENT
“…we are taking a powerful, proven, low-cost system and broadening its application to higher value tests over time.”
Read more.
POINT OF CARE MARKET EXPECTED TO GROW STRONGLY
The point-of-care diagnostics market is forecast to grow strongly in the next five years, with research predicting the global sector to reach $US18 billion by 2020.
Read more.
SPREADING THE UBI WORD
UBI CEO Paul Wright has been promoting the company around Australia and the world, presenting in almost every Australian capital city and in the US, Asia and Europe.
J&J SYNCS BLOOD GLUCOSE DATA WITH APPLE HEALTH APP
Johnson & Johnson’s LifeScan has announced data collected on its blood glucose devices can now be synced with Apple’s Health app on iPhones.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
